We came across a bullish thesis on Collegium Pharmaceutical, Inc. on The Catholic Capitalist’s Substack by Logan Shearer. In this article, we will summarize the bulls’ thesis on COLL. Collegium Pharmaceutical, Inc.'s share was trading at $35.16 as of September 24th. COLL’s trailing and forward P/E were 32.92 and 4.87 respectively according to Yahoo Finance.
Collegium Pharmaceuticals (COLL) represents a compelling investment opportunity that is currently underappreciated by the market. The company has historically been stigmatized as a “melting icecube” due to its focus...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.